Back
First Trust Nasdaq Pharmaceuticals ETF 10K Form
Sell
41
FTXH
First Trust Nasdaq Pharmaceuticals ETF
Last Price:
27.74
Seasonality Move:
4.46%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive FTXH News And Ratings
See the #1 stock for the next 7 days that we like better than FTXH
FTXH Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.00 |
| Price / Book: | 0 |
Profitability
| Net Income (TTM): | $0 |
|---|---|
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
First Trust Nasdaq Pharmaceuticals ETF Earnings Forecast
Key First Trust Nasdaq Pharmaceuticals ETF Financial Ratios
First Trust Nasdaq Pharmaceuticals ETF Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Current Symbol: | FTXH |
| CUSIP: | 33738R |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
FTXH Technical Analysis vs Fundamental Analysis
Sell
41
First Trust Nasdaq Pharmaceuticals ETF (FTXH)
is a Sell
Is First Trust Nasdaq Pharmaceuticals ETF a Buy or a Sell?
-
First Trust Nasdaq Pharmaceuticals ETF stock is rated a Sell
The current First Trust Nasdaq Pharmaceuticals ETF [FTXH] share price is $28.09. The Score for FTXH is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.